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base. Patients with an echo performed within 7 days of admission (1x227) were included 
in this analysis. Acute physiology (APACHE II) scores, used as a marker of illness sever- 
ity, and heart failure (CHF) by Framingham criteria were determined retrospectively. Dif- 
ferences in clinical, microbiologic and echo variables between patients who died during 
index hospitalization and those who suwved to discharge were assessed by univariable 
analysis. Logistic regression analysis was used to determine characterist!cs Indepen- 
dently associated with in-hospital mortality. 
Results: Patients with IE had a median age of 60*16 years. There were 100 (44%) 
women. 76 (33%) had diabetes mellitus (DM). 64 (26%) were on hemodialysis, and 44 
(19%) had prosthebc valves. Median duration of symptoms prior to admission was 4 
days, and CHF was present in 73 (32%). 54 (24%) patients underwent cardiac surgery 
during index hospitakzatlon. Compared to patients who survived to discharge (n=l66). 
patients who died during admission (n=41, 16%) were similar with respect to CHF, echo 
findings, embolic events and rate of surgery. In contrast, patients that died were more 
likely to have DM (56% vs. 26%), higher median APACHE II score (17 vs. II), S. aureus 
InfectIon (77% vs. 33%), and persistent bacteremia (39% vs. 16%) (~~0.05 for each). In 
multivariable analysis, only DM (OR 2.6, 95% Cl 1.2-5.7) and S. aureus infection (OR 
3.1,95% Cl 1.2-7.6) were independently associated with in-hospital mortality. 
Conclusion: ControllIng for severity of illness, the early predictors of mortality in IE are 
the presence of DM and S.aureus infection. These results suggest a role for host-patho- 
gen factors in Identifying patients at high risk for mortality who may be targeted for 
aggressive care. 
I:48 pm 
1109MP-172 Left-Sided Valvular Disease in Carcinoid Syndrome: 
Underestimation Without Repetitive 
Echocardiographiee 
Nicolas Mansencal, Franck Digne, Emmanuel Mitry, Jean-Franqois Fonssier, Thverry 
Joseph, Pascal Lacombe, Guillaume Jondeau, Philippe Rougler, Olivia Dubourg, 
Hhpital Ambroise Park, Boulogne, France 
Background: Right-sided valvular disease is well known iri carcinoid syndrome but little is 
known about the left-sided valvular disease. The aim of our study was to assess the inci- 
dence of both right and left-sided valvular diseases and to determine the role of patent 
foramen wale (PFO) with this left-sided valvular disease. 
Methods: Sixty-three consecutwe trans-thoracic echocardiographies (TTE) have been 
performed in 26 pts (mean age 59 * 6 years, 54% women) presenting with carcinoid syn- 
drome. The echocardiographic following parameters were assessed: 1) right-sided valvu- 
lar disease, 2) left-sided valvular disease, 3) right to left shunting through a patent 
foramen wale (PFO +) using contrast echocardlography at rest and after cough test or 
vasa1va rnane”“er. 
Results: Mean follow-up was 21 * 20 months. At control, TrE revealed 7 pts (27%) with 
right-sided valvular carcinoid disease (RVCD), 3 pts (12%) with left-sided valvular carci- 
nold disease (LVCD) and 8 PFO + (31%). At the end of follow-up, the incidence of 
RVCD, LVCD and PFO + was 36% (10 pts), 31% (6 pts) and 36% (10 pts) respectively. 
All patients with RVCD and PFO + (7 patients) exhiblted progresslo” or new appearance 
of left-sided valvular disease. Six patients (75%) had both LVCD and PFO +. 
Conclusion: According to follow-up, our data suggest that the incidence of left-slded val- 
vular injury might be underestimated in carcinoid syndrome without repetitive echocar- 
diographles. PFO + resulting in right to left shunting seems to be a major factor of left- 
sided valvular ~n]ury and should be systematically researched in carcinoid syndrome. 
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824FO-2 Atorvaetatin Inhibits Aortic Valve Calcification in an 
Experimental Model of Chronic Hypercholeeterolemia 
via Nonlipid Lowering Effects 
Nalini M. Raiamannan, Malayannan Subramaniam. Margaret Spring&t. Marek Neikrasz. 
Stuart R. Stock, Konstantine I. Ignatiev, Joseph McConnell, Ravinder Singh, Neil Stone. 
Robert 0. Bonow, Thomas C. Spelsberg, Northwestern University, Chicago, IL, Mayo 
Clinic, Rochester, MN 
Intro: Calcific aortic valve disease is the third most common indication for aortic valve 
(AV) replacement I” the USA. To further understand the cellular mechanisms of calcific 
aortic stenosis, we tested a model of chronic experimental hypercholesterolemia for cal- 
cification and also the non-lipid lowering effects of atorvastabn in the AV. Methods: Rab- 
bits (n=46) were treated for 3 months: Group I: normal diet, Group II: 0.5% (w/w) chol 
diet, and Group III: 0.5% (w/w) chol diet + atow (3mglkgiday). Masson Trichrome (MT) 
stain was performed for mineralization. Serum chol and high-sensitwlty C-reactwe pro- 
tan (hsCRP) levels were obtained by standard assays. Serum nrtrlte levels were mea- 
sured with a nitric oxide analyzer. lmmunoblots and immunohistochemistry were 
performed to measure the eNOS protein. MicroCT scans were performed for evaluation 
of calcification in the AV. Results: There was an increase an chol. hsCRP and calcification 
in Group II AV compared to Group I. Atorv inhibited calcification in the AV as assessed 
by micro-CT. Serum nitrite levels, eNOS protein expression (3.fold) and eNOS local~za- 
tion were decreased in Group II AV and increased in the Group Ill. MT stain demon- 
strated mineralization in the Group II AV. Concl: This finding of calcification in the AV 
during chronic experimental hyperchol provides evidence of bone mineralization in the 
aorl~c valve. Furlhermore, this bone mineralization is inhibited by atorv and may be medi- 
ated by anti-inflammatory effects of atorv. 
Chol (mgldl) 
hsCRP (mg/dl) 
Nitrites (nM) 
Group I 
45k5.6 
0.03*0.005 
994.67+/-392.51 
Group II 
1726i 637’ 
0.41*0.19 ’ 
196.17+/-106.83^*’ 
Group III 
1066r503 
0.04* 0.04” 
745+/-340.7Y’ 
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824FO-3 Tumor Necrosis Factor Alpha Induces Calcification of 
Aortic Valve Myofibroblaete 
Jens J. Kaden Aslihan Sarikoc. Refika Kilic, Karl K. Haase, Carl-Erik Dempfle, Martin 
Borggrefe, University Hospital Mannheim, Mannheim, Germany 
Background:Tumor necrosis factor alpha (TNF) induces calcification of arterial smooth 
muscle cells in vitro. Calcific aortic stenosis, the most prevalent heart valve disease in 
the elderly, is characterized by massive tissue calafication. We have shown recently that 
TNF is upregulated in stenotic aortic valves, and that it IS associated with the remodeling 
of the extracellular matrix in this disorder. The influence of TNF on the pathogenesis of 
valvular calcification is unknown. 
Methods: Human aortlc valve myofibroblasts were isolated from explanted aortic valves. 
Confluent cells were grown in Dulbecco’s modified Eagle’s medium supplemented with 
10% fetal calf serum, 50 mg/mL ascorbic acid, and 50 mmoUL beta-glycerophosphate, 
with and without 100 nglmL TNF. After 21 days, calcified cell nodules were counted. In 
total cell lysates, the expression of bone-type alkaline phosphatase and osteocalcin were 
assessed by wnmunoassay, alkaline phosphatase activity was measured by a kinetic 
assay, and calcium concentrations were determined by the cresolphthalein complexone 
method. 
Results: Cells treated wth TNF showed a 19-fold increase in nodule formation as com- 
pared to control. In cell lysates, Incubation with TNF resulted in a 20-fold increase in 
bone-type alkaline phosphatase expression, a 7-fold increase in osteocalcin expression, 
a 3.fold increase in alkaline phosphatase activity and a 3-fold increase in calcium con- 
centration as compared to control. 
Conclusion: TNF induces en osteoblast-like phenotype in cultured human aortic valve 
myofibroblasts in vitro, es indicated by increased nodule formatton. expression of osteo- 
blast-associated genes and calcification. These results suggest that valvular calclficahon 
in cakific aortic stenosis may be actively regulated, involving an inflammatory process. 
This could could be a potential target for modification of valvular calcification in calcific 
aortic stenosis. 
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824FO-4 Relation of kortic Valve Calcification With 
Cardiovascular Risk Factors and Antiinflammatory 
Gene Polymorphisms in Patients With Degenerative 
Calcific Aottic Stenosis 
Jan R. Ortlepg Fabian Schmitz, Vera Mevissen, Stephan Weil3, Richard Dronskowskl, 
Klaus Zerres, Christian Weber, Riidiger Autschbach, Bruno Messmer, Peter Hanrath, 
Rainer Hoffman”, University Hospital of Aachen, Aachen, Germany, lnstltute of lnorganlc 
Chemistry, RWTH Aachen. Aachen. Germany 
Background: Calclficatlon of the aorilc valve mtght be influenced by the prevalence of 
cardiovascular risk factors (CRF), whereas the influence of genetic factors remains 
uncertain. 
Methods: [Ca5 (P04)30H] of 190 excised aortic valves with degenerative calcific aortic 
stenosis was determined using calcium atomic absorption analysis. Left heart catheter- 
ization, assessment of CRF and genotyping of the antiinflammatory lnterleukln 10 and 
chemokine receptor CCR5 polymorphisms were performed. 
Results: There was a positive correlation of calciftcation (quIntlIes) with the mean gradi- 
ent across the aortic valve (44 * 14, 52 * 16, 54 * 16.61 f 15,68 * 19 mmHg; pcO.001). 
Males had a hither dearee of calcification than females (26.2 * 8.9 versus 20.6 + 9.4 
mass%; p<O.OOl), des;te having the same mean gradient across the aortic valve (56 * 
17 versus 56 f 19 mmHo: o=O.9551. None of the investiaated CRF was associated with 
_ . I  
the degree of calcification. lnterleukin 10 promotor polymorphisms -1062. -619, and -592 
were significantly associated with the degree of calcification (haplotypes: 17.9 * 9.0 ver- 
sus 24 5 f 6.3 versus 25.4 * 9 4 mass%; pcO.001). This was pronounced if certain allele 
carriers had also the CCA5 D32 allele (haplotypes plus CCRB: 17.9 * 9.0 versus 24.5 r 
6.5 versus 27.5 r 10.9 mass%; p<O.oOl). 
Conclusion: CRF do not determlne the amount of aortic valve calcification. However, 
gender and genetic polymorphism of the interleukin 10 and CCR5 gene are associated 
with the degree of aortic valve calcification. 
